Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy Editorial

  

Authors:	Mondello, P.; Zelenetz, A. D.
Title:	Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy
Keywords:	gene mutation; fludarabine; hypertension; monotherapy; note; rituximab; progression free survival; infection; bone marrow suppression; bleeding; blood toxicity; bendamustine; cyclophosphamide; tumor suppressor gene; acute leukemia; myelodysplastic syndrome; minimal residual disease; comorbidity; chronic lymphatic leukemia; atrial fibrillation; chlorambucil; leukemia remission; molecularly targeted therapy; immunoglobulin heavy chain gene; ibrutinib; human; priority journal; obinutuzumab; venetoclax; acalabrutinib
Journal Title:	British Journal of Haematology
Volume:	191
Issue:	3
ISSN:	0007-1048
Publisher:	John Wiley & Sons
Date Published:	2020-11-01
Start Page:	326
End Page:	328
Language:	English
DOI:	10.1111/bjh.17031
PUBMED:	32761826
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089020204&doi=10.1111%2fbjh.17031&partnerID=40&md5=e0a12c92e397b6455d83ee85895fbffa
Notes:	Note -- Export Date: 1 December 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/173297